CLOSEOUT LETTER
Reasy Farms
- Recipient:
- Reasy Farms
United States
- Issuing Office:
United States
| |
PHILADELPHIA DISTRICT U.S. CUSTOMHOUSE 2ND AND CHESTNUT STREETS ROOM 900 PHILADELPHIA, PA 19106 TELEPHONE: 215-597-4390 |
CERTIFIED MAIL
RETURN RECEIPT REQUESTED
January 20, 2017
Mr. Chris A. Reasy, Owner/Operator
Reasy Farms
869 Kings Road
New Enterprise, Pennsylvania 16664
Dear Mr. Reasy:
The Food and Drug Administration has completed an evaluation of your firm's corrective actions in response to our Warning Letter 16-PHI-01 issued January 5, 2016. Based on our evaluation, it appears that you have addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.
This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.
Sincerely,
/S/
Steven L. Carter
Director, Compliance Branch
Philadelphia District Office